サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1794621

超音波乳化吸引装置の世界市場

Phacoemulsification Devices

出版日
ページ情報
英文 278 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
超音波乳化吸引装置の世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 278 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

超音波乳化吸引装置の世界市場は2030年までに27億米ドルに到達

2024年に21億米ドルと推定される超音波乳化吸引装置の世界市場は、分析期間2024-2030年にCAGR 4.3%で成長し、2030年には27億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるPhacoemulsification Consumablesは、CAGR 5.1%を記録し、分析期間終了時には18億米ドルに達すると予測されます。Phacoemulsificationシステム分野の成長率は、分析期間中CAGR 2.8％と推定されます。

米国市場は5億8,170万米ドルと推定、中国はCAGR8.0％で成長予測

米国の超音波乳化吸引装置市場は、2024年に5億8,170万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年にかけてCAGR 8.0%で推移し、2030年には5億6,840万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.4%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界の超音波乳化吸引装置市場- 主要動向と促進要因のまとめ

超音波乳化吸引装置の需要が世界的に高まっているのはなぜか？

超音波乳化吸引装置の世界需要は、特に高齢化社会における白内障の有病率の上昇により、着実に急増しています。白内障は、世界的に視覚障害や失明の主な原因の1つであり、白内障手術では、低侵襲で回復が早く、成功率が高い超音波乳化吸引術がゴールドスタンダードとなっています。特に北米、欧州、アジア太平洋の一部などの地域では高齢者人口が増加しており、効率的で安全かつ信頼性の高い白内障治療の必要性が高まっています。政府やヘルスケアシステムは、特に予防可能な失明を減らすことを公衆衛生に義務付けている国々において、増大する患者負担を管理するために眼科医療インフラに多額の投資を行っています。さらに、患者の意識が高まり、より良い手術結果が得られやすくなったことが、従来の嚢外白内障摘出法よりも超音波乳化吸引法の急速な普及に寄与しています。最新の超音波乳化吸引システムが提供する利便性と精度は、新興市場における可処分所得の増加や医療保険の利用可能性の向上と相まって、これらの先進的な機器の普及をさらに後押ししています。さらに、慈善事業やNGO主導のイニシアチブは、十分なサービスを受けていない地域に超音波乳化吸引術の技術を導入する上で重要な役割を果たしており、市場の裾野を広げています。このような視覚の健康への関心の高まりは、QOLと機能的長寿が世界的に重視され続けていることから、さらに加速すると予想されます。

技術の進歩は眼科手術の精度をどのように再定義しているか？

超音波乳化吸引装置における技術革新は、手術精度、安全性、患者の転帰を劇的に改善しています。最新の機器には高度なフルイディクスシステム、術中リアルタイムフィードバック、熱損傷を最小限に抑え水晶体除去効率を向上させるエネルギー調節機能が搭載されています。マイクロ切開白内障手術（MICS）へのシフトは、手術のコントロールを損なうことなく、より小さな切開を容易にする、よりコンパクトで洗練されたハンドピースと機械に対する需要を生み出しています。ねじり超音波技術、インテリジェント吸引コントロール、統合型光干渉断層計（OCT）などの技術革新は、白内障手術の実施方法を一変させました。現在では多くのシステムが、レンズの硬度、患者の眼の解剖学的構造、および外科医の好みに基づいてカスタマイズ可能な設定を提供し、合併症の減少を伴う最適化された結果をもたらしています。タッチスクリーン・インターフェースとクラウド接続の統合により、リアルタイムのデータ追跡と手術成績分析が可能になり、手技トレーニングと標準化の両方が強化されています。さらに、フェムトセカンドレーザー支援白内障手術（FLACS）の台頭は、水晶体破砕と被膜切開の精度を向上させることで、乳化吸引術を補完しています。業界各社は、システムの人間工学的、エネルギー効率、応答性を高めるため、研究開発に多額の投資を行っています。このような技術革新は、臨床結果を向上させるだけでなく、より新しい外科医集団に機器の使いやすさを広げることにもつながります。この分野が進化を続けるにつれ、ハイテク超音波乳化吸引システムは、よりインテリジェントで侵襲性が低く、個々の手術のニーズに合わせたものとなっていくでしょう。

ヘルスケア・インフラと手術トレーニングは市場浸透にどのような役割を果たすか？

超音波乳化吸引装置の普及と採用は、熟練した眼科外科医の有無と医療インフラの充実度に大きく影響されます。最先端の手術設備へのアクセスが一般的である高所得国では、白内障摘出術はほぼ完全に超音波乳化吸引術に取って代わられています。しかし、中低所得国の多くでは、訓練を受けた外科医の不足や手術センターの設備不足のため、超音波乳化吸引装置の本格的な導入には依然として限界があります。このギャップを埋めるために、いくつかのメーカーや非営利団体が、世界のアウトリーチプログラムを通じて、教育やスキルアップの取り組みに力を入れています。体系化されたトレーニングモジュール、バーチャルリアリティシミュレーター、ライブ手術ワークショップは、新世代の眼科医に超音波乳化吸引術の技術を習得させるのに役立っています。同時に、新興国では外来手術センターや私立眼科病院の急増により、高品質で費用対効果の高い手術システムへの新たな需要が生まれています。白内障手術を含む保険適用や政府後援の医療プログラムも患者数を増加させ、医療機関に超音波乳化吸引システムへの投資を促しています。さらに、手術プロトコルと認定要件の標準化により、国際的な治療基準を満たすために先進的な機器を導入する病院が増えています。白内障による失明の世界の負担が増大する中、これらの技術を広く普及させるには、手術能力と臨床医の専門知識の拡大が不可欠です。ヘルスケアの提供とスキル開拓に的を絞った投資により、多くの未開拓市場は加速度的に成長する態勢が整っています。

超音波乳化吸引装置市場を牽引する主な成長促進要因とは？

超音波乳化吸引装置市場の成長は、技術の高度化、人口動態の変化、ヘルスケア提供モデルの進化に関連するいくつかの要因によってもたらされます。主な要因としては、世界人口の急速な高齢化が挙げられ、これに伴い加齢に伴う白内障の罹患率が高くなり、その結果、外科手術の必要性が高まっています。これと並行して、改良された流体力学、リアルタイムの手術分析、適応性の高いエネルギー供給システムなど、機器機能の継続的な進歩により、手術成績と患者の安全性が大幅に向上しています。低侵襲手技や精密機器に対する外科医の嗜好の高まりは、白内障摘出術の望ましい方法として超音波乳化吸引術をさらに強固なものにしています。ヘルスケア提供側では、個人眼科クリニック、外来手術センター、眼科専門ネットワークの拡大が、コンパクトで持ち運びができ、拡張性のある手術システムへの需要を高めています。消費者の行動も重要な役割を果たしており、患者はより早い回復、高精細な視覚結果、レーザー支援によるカスタマイズをますます求めるようになっています。インドや中国のような国では政府が資金を提供する白内障撲滅プログラムがあり、欧米諸国では体系化された償還の枠組みがあるため、これらの先進的なシステムに財政的な実行可能性とアクセスしやすさがもたらされています。さらに、選択的白内障手術の増加や、二次医療センターや農村部の医療センターへの白内障手術の拡大は、機器メーカーに新たな道を開いています。最後に、手術トレーニングと機器規制の世界の調和により、新技術の市場投入までの時間が短縮され、競争力のある技術革新が促進され、地域間でより幅広い製品が利用できるようになっています。

セグメント

製品（超音波乳化吸引術用消耗品、超音波乳化吸引術用システム）;エンドユーザー（病院エンドユーザー、クリニックエンドユーザー、調査機関エンドユーザー）

調査対象企業の例

  • Alcon
  • Appasamy Associates
  • Bausch+Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos（a Nikon company）
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37719

Global Phacoemulsification Devices Market to Reach US$2.7 Billion by 2030

The global market for Phacoemulsification Devices estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Phacoemulsification Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Phacoemulsification Systems segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$581.7 Million While China is Forecast to Grow at 8.0% CAGR

The Phacoemulsification Devices market in the U.S. is estimated at US$581.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$568.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Phacoemulsification Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Phacoemulsification Devices Rising Across the Globe?

The global demand for phacoemulsification devices is witnessing a steady surge due to the rising prevalence of cataracts, particularly among the aging population. Cataracts remain one of the leading causes of visual impairment and blindness globally, and phacoemulsification has become the gold standard in cataract surgery due to its minimally invasive nature, faster recovery time, and high success rate. The increasing geriatric demographic, especially in regions like North America, Europe, and parts of Asia-Pacific, has driven the need for efficient, safe, and reliable cataract treatment options. Governments and healthcare systems are investing significantly in ophthalmic care infrastructure to manage the growing patient burden, particularly in countries with public health mandates to reduce preventable blindness. Moreover, increased patient awareness and the accessibility of better surgical outcomes are contributing to the rapid adoption of phacoemulsification over traditional extracapsular cataract extraction methods. The convenience and precision offered by modern phacoemulsification systems, combined with rising disposable incomes and greater availability of health insurance in emerging markets, have further encouraged the uptake of these advanced devices. Additionally, philanthropic and NGO-led initiatives are playing a significant role in bringing phacoemulsification technologies to underserved areas, broadening the market reach. This increased focus on visual health is expected to accelerate further with continued global emphasis on quality of life and functional longevity.

How Are Technological Advancements Redefining Surgical Precision in Ophthalmology?

Technological innovations in phacoemulsification devices are dramatically improving surgical precision, safety, and patient outcomes. Modern devices now come equipped with advanced fluidics systems, real-time intraoperative feedback, and enhanced energy modulation capabilities that minimize thermal damage and improve lens removal efficiency. The shift toward microincision cataract surgery (MICS) has created a demand for more compact and sophisticated handpieces and machines that facilitate smaller incisions without compromising surgical control. Innovations such as torsional ultrasound technology, intelligent aspiration control, and integrated optical coherence tomography (OCT) have transformed how cataract surgeries are performed. Many systems now offer customizable settings based on lens hardness, patient eye anatomy, and surgeon preferences, resulting in optimized outcomes with reduced complications. Integration of touchscreen interfaces and cloud connectivity allows real-time data tracking and surgical performance analysis, which enhances both procedural training and standardization. Furthermore, the rise of femtosecond laser-assisted cataract surgery (FLACS) is complementing phacoemulsification procedures by improving lens fragmentation and capsulotomy precision. Industry players are investing heavily in R&D to make systems more ergonomic, energy-efficient, and responsive. Such innovations not only boost clinical outcomes but also expand the usability of devices to newer surgeon cohorts. As the field continues to evolve, high-tech phacoemulsification systems are poised to become even more intelligent, less invasive, and tailored to individual surgical needs.

What Role Do Healthcare Infrastructure and Surgical Training Play in Market Penetration?

The spread and adoption of phacoemulsification devices are heavily influenced by the availability of skilled ophthalmic surgeons and the robustness of healthcare infrastructure. In high-income countries, where access to state-of-the-art surgical facilities is more common, phacoemulsification has almost entirely replaced older cataract extraction techniques. However, in many low- and middle-income nations, the lack of trained surgeons and under-equipped surgical centers continues to limit the full-scale adoption of phacoemulsification devices. To bridge this gap, several manufacturers and non-profit organizations are focusing on education and skill-building initiatives through global outreach programs. Structured training modules, virtual reality simulators, and live surgical workshops are helping to train a new generation of ophthalmologists in phacoemulsification techniques. At the same time, the proliferation of ambulatory surgical centers and private eye hospitals in emerging economies is creating new demand for high-quality, cost-effective surgical systems. Insurance coverage and government-sponsored health programs that include cataract surgery have also boosted patient volumes, prompting institutions to invest in phacoemulsification systems. Moreover, standardization of surgical protocols and accreditation requirements is encouraging more hospitals to adopt advanced equipment to meet international care benchmarks. As the global burden of cataract-related blindness grows, expanding surgical capacity and clinician expertise will be essential to enabling widespread adoption of these technologies. With targeted investment in healthcare delivery and skills development, many underpenetrated markets are poised for accelerated growth.

What Are the Key Growth Drivers Powering the Phacoemulsification Devices Market?

The growth in the phacoemulsification devices market is driven by several factors related to technological sophistication, changing demographics, and evolving healthcare delivery models. A primary driver is the rapid aging of the global population, which is leading to a higher incidence of age-related cataracts and consequently, a greater need for surgical intervention. In parallel, the continuous advancement of device functionality such as improved fluidics, real-time surgical analytics, and adaptive energy delivery systems has significantly elevated surgical outcomes and patient safety. Increasing surgeon preference for minimally invasive techniques and precision tools has further solidified phacoemulsification as the preferred method of cataract removal. On the healthcare delivery side, the expansion of private eye clinics, outpatient surgical centers, and specialized ophthalmology networks has amplified the demand for compact, portable, and scalable surgical systems. Consumer behavior is also playing a critical role, with patients increasingly seeking faster recovery, high-definition visual outcomes, and laser-assisted customization. Government-funded cataract elimination programs in countries like India and China, as well as structured reimbursement frameworks in Western nations, have provided financial viability and accessibility to these advanced systems. Additionally, the growing volume of elective cataract procedures and the expansion of cataract surgery into secondary and rural healthcare centers are opening new avenues for device manufacturers. Lastly, the global harmonization of surgical training and device regulation is accelerating time-to-market for new technologies, fueling competitive innovation and broader product availability across regions.

SCOPE OF STUDY:

The report analyzes the Phacoemulsification Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Phacoemulsification Consumables, Phacoemulsification Systems); End-Use (Hospitals End-Use, Clinics End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Alcon
  • Appasamy Associates
  • Bausch + Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos (a Nikon company)
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Phacoemulsification Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cataracts Propels Demand for Phacoemulsification Devices
    • Aging Population Trends Expand the Addressable Market for Minimally Invasive Eye Surgeries
    • Technological Advancements in Ultrasound Energy Delivery Drive Innovation in Phacoemulsification Systems
    • Improved Fluidics and Real-Time Feedback Mechanisms Strengthen the Business Case for Next-Gen Devices
    • Increased Surgical Volume in Emerging Markets Spurs Demand for Compact and Cost-Effective Systems
    • Shift Toward Day Surgery and Ambulatory Cataract Procedures Throws the Spotlight on Portable and Rapid-Cycle Devices
    • Rising Demand for Precision and Customization Drives Integration of Digital Imaging and AI-Enabled Platforms
    • Healthcare Infrastructure Expansion in Asia-Pacific and Latin America Fuels Equipment Procurement Growth
    • Preference for Single-Use Handpieces and Consumables Generates Recurring Revenue Streams
    • Surge in Demand for Premium Intraocular Lenses (IOLs) Supports Growth in Advanced Phaco Systems
    • Increased Focus on Surgical Safety and Efficiency Throws the Spotlight on Ergonomic and User-Centric Designs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Phacoemulsification Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Phacoemulsification Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Phacoemulsification Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION